Reduced adiposity and improved insulin sensitivity in obese mice with antisense suppression of 4E-BP2 expression

American Journal of Physiology. Endocrinology and Metabolism
Xing Xian YuSanjay Bhanot

Abstract

To investigate the possible role of eukaryotic initiation factor 4E-binding protein-2 (4E-BP2) in metabolism and energy homeostasis, high-fat diet-induced obese mice were treated with a 4E-BP2-specific antisense oligonucleotide (ASO) or a control 4E-BP2 ASO at a dose of 25 mg/kg body wt or with saline twice a week for 6 wk. 4E-BP2 ASO treatment reduced 4E-BP2 levels by >75% in liver and white (WAT) and brown adipose (BAT) tissues. Treatment did not change food intake but lowered body weight by approximately 7% and body fat content by approximately 18%. Treatment decreased liver triglyceride (TG) content by >50%, normalized plasma glucose and insulin levels, and reduced glucose excursion during glucose tolerance test. 4E-BP2 ASO-treated mice showed >8.5% increase in metabolic rate, >40% increase in UCP1 levels in BAT, >45% increase in beta(3)-adrenoceptor mRNA, and 40-55% decrease in mitochondrial dicarboxylate carrier, fatty acid synthase, and diacylglycerol acyltransferase 2 mRNA levels in WAT. 4E-BP2 ASO-transfected mouse hepatocytes showed an increased fatty acid oxidation rate and a decreased TG synthesis rate. In addition, 4E-BP2 ASO-treated mice demonstrated approximately 60 and 29% decreases in hepatic glucose-6-phosphat...Continue Reading

References

Apr 26, 1994·Proceedings of the National Academy of Sciences of the United States of America·C HuJ C Lawrence
Jan 13, 1994·Biochimica Et Biophysica Acta·N T Redpath, C G Proud
May 1, 1997·Endocrinology·J F TantiY Le Marchand-Brustel
Feb 12, 1998·The Journal of Biological Chemistry·P J BlackshearJ C Lawrence
Jun 5, 1998·The Journal of Biological Chemistry·F PoulinN Sonenberg
May 18, 1999·Molecular and Cellular Biology·Q WangA Klip
May 23, 2001·Experimental Biology and Medicine·R V Farese
Oct 9, 2001·Nature Medicine·K Tsukiyama-KoharaN Sonenberg
Aug 18, 2004·Genes & Development·Nissim Hay, Nahum Sonenberg
Feb 4, 2005·Nature·Joel D Richter, Nahum Sonenberg
Feb 4, 2005·The Journal of Clinical Investigation·Hajime KandaMasato Kasuga
Jul 8, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Xing Xian YuSanjay Bhanot
Aug 17, 2005·Genes & Development·Aurelio A TelemanStephen M Cohen
Oct 21, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Jessica L BankoEric Klann
Nov 3, 2005·American Journal of Physiology. Endocrinology and Metabolism·Thomas C Vary, Christopher J Lynch
Feb 2, 2006·Annals of Medicine·Enzo Bonora
Feb 24, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Jessica L BankoEric Klann
May 6, 2006·FEBS Letters·Yuji Matsuzawa
Oct 13, 2006·Neurobiology of Learning and Memory·Jessica L BankoEric Klann
Feb 3, 2007·The Journal of Clinical Investigation·Olivier Le BacquerNahum Sonenberg
May 23, 2007·Molecular and Cellular Biology·Takeshi YoshizakiJerrold M Olefsky
Oct 14, 2008·British Dental Journal·A J IrelandJ R Sandy

❮ Previous
Next ❯

Citations

Oct 9, 2013·Nature Medicine·Matthew Harms, Patrick Seale
Aug 2, 2008·American Journal of Physiology. Gastrointestinal and Liver Physiology·Gladys M VarelaRexford S Ahima
Mar 2, 2012·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Rotonya M CarrRexford S Ahima
Aug 13, 2008·Journal of Burn Care & Research : Official Publication of the American Burn Association·Gerd G GauglitzMarc G Jeschke
Feb 25, 2009·Expert Opinion on Therapeutic Targets·Philip HallenborgKarsten Kristiansen
Sep 10, 2009·American Journal of Physiology. Endocrinology and Metabolism·Nattida ChotechuangDaniel Tomé
Feb 27, 2021·Frontiers in Cell and Developmental Biology·Ningxin QinHefeng Huang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Related Papers

Prostaglandins, Leukotrienes, and Essential Fatty Acids
Toshiyuki FukaoGrant A Mitchell
The Journal of Pharmacology and Experimental Therapeutics
Sunwoo ParkC Anthony Hunt
Biotechnology and Bioengineering
Jean Matthieu ProtEric Leclerc
© 2021 Meta ULC. All rights reserved